7Piarroux R,Grenouillet F,Balvay P,et al.Assesment of preemptive treatment to preventsevere candidiasis in critically ill surgical patients[J].Crit Care Med,2004,32(12):2 443.
8Douglas LJ.Candida biofilms and their role in infection[J].Trends Microbiol,2003,11(1):30.
6Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998[J].Antimicrob Agents Chemother, 2000, 44(3):747-751.
7Sobel JD, Zervos M, Reed BD,et al. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications[J]. Antimicrob Agents Chemother, 2003,47(1): 34-38.
8Safdar A, Chaturvedi V, Koll BS, et al. Prospective, multicenter surveillance study of Candida glabrata: fluconaole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City[J]. Antimicrob Agents Chemother, 2002,46(10): 3268-3272.
9Holland J, Young ML, Lee O, et al. Vulvaginal carriage of yeasts other than Candida albicans[J]. Sex Transm Infect,2003,79(3):249-50.
10St-Germain G, Laverdiere M, Pelletier R, et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally surveillance study in Quebec,Canada[J]. J Clin Microbiol, 2001, 39(3):949-953.
3Pfaller M, Pappas P, Wingard J. Invasive fungal pathogens : current epidemiological trends [ J ]. Clin Infect Dis, 2006,43 ( Supplement 1 ) : S3 - S14.
4E1-Ebiary M,Tones A,Fabregas N, et. al. Significance of the Isola- tion of Candida Species from Respiratory Samples in Critically Ill, Non-neutropenic Patients. An Immediate Postmortem Histologic Study[J]. Am J Respir Crit Care Med,1997,156(2) :583 -590.